- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Cobimetinib, as a MEK1/2 inhibitor, has significant therapeutic effects on BRAFV600 mutation positive unresectable or metastatic melanoma. Its ...
The use of Cobimetinib should strictly follow the indications and combination therapy regimen. It is mainly suitable for BRAFV600 mutation posi...
The duration of taking Cobimetinib depends on the medication regimen and individual tolerance, and it is usually recommended to take it at a fi...
Cobimetinib is a selective MEK1/2 inhibitor that exerts anti-tumor effects by blocking the RAS/RAF/MEK/ERK signaling pathway. It is mainly used...
Eroxon gel is a topical drug, which is mainly used to treat male erectile dysfunction (ED), improve penis blood flow through local action, and ...
Eroxon gel is a topical medication for erectile dysfunction. It can improve penis blood flow through local action. Its efficacy and safety have...
Ponatinib, as an important drug for the treatment of specific leukemia, has contraindications mainly related to cardiovascular risk, special po...
Whether Ponatinib, as a third-generation BCR-ABL tyrosine kinase inhibitor, is marketed in China is an important information that patients want...
The use of Ixazomib involves key elements such as dosage regimen, administration method, and treatment cycle, and must be strictly adjusted a...
Lazertinib, as a targeted drug for EGFR mutant non-small cell lung cancer, has clear restrictions on its use, including contraindications for s...
